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ABSTRACT 
Introduction: Cervical cancer affects women without access to preventative screening at 
higher rates. Any woman who has developed an invasive case of cervical cancer should be 
regarded as a failure of screening. Disparities in access to screening, triage, and treatment fuel an 
uneven distribution in the burden of cervical cancer within the United States; especially in southern 
states like Arkansas. The purpose of this study was to evaluate demographic and behavioral risk 
factors for cervical cancer and identify potential barriers which may influence the likelihood of 
complying with current Pap test recommendations nationally and in Arkansas. 
Materials and Methods: Data from the 2014 Behavioral Risk Factor Survey System 
(BRFSS) was used to describe demographic characteristics and behavioral risk factors among 
1,587 females in Arkansas and 162,222 in the United States aged 18 and above who were eligible 
to receive Pap tests. Women with a medical history of hysterectomy that included the removal of 
the cervix were excluded from analysis because they are not considered to be medically eligible to 
receive Pap tests. 
Results: Socioeconomic status, age, race, and health insurance were significantly 
associated with the likelihood to comply with current screening recommendations among women 
in both Arkansas and the United States. Arkansan women who had less than a 12-year education 
(Odds Ratio (OR) = 1.41, 95% Confidence Interval (CI) = 1.04, 1.64) and were without health 
insurance (OR = 3.56, 95% CI = 1.66, 7.66) were more likely to be non-compliant with Pap testing, 
which was similar to the finding on the national level. The prevalence of Pap test compliance was 
significantly lower among women in Arkansas when compared to the national average in every 
sociodemographic sector.    
Discussion: According to United States Census data collected in 2013, Arkansas had the 
highest cervical cancer incidence of 10.6 per 100,000 person-years, while the national average was 
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7.7 per 100,000 person-years. Therefore, future population-based cervical cancer interventions in 
Arkansas should target the promotion of Pap test compliance among women of minority 
populations, with low socioeconomic status, and who are medically under or uninsured. Organized 
screening interventions might include offering free or reduced cost Pap testing in both urban and 
rural locations. 
Keywords: Cervical cancer; screening; Pap test; disparities; Arkansas 
INTRODUCTION 
Ranked globally as the fourth most common female malignancy, cervical cancer (CC) is 
undoubtedly a global public health concern (Kessler, 2017). The global incidence of CC is an 
estimated 527,624 new cases annually with 265,672 deaths as a result (Bruni, 2016). CC is the 
third most common cause of death worldwide for women who live in low-resource or less 
developed countries (Kessler, 2017). Women who are poor and live in rural areas of low and 
middle-income countries, as well as women who are poor and live in high-income countries, are 
at an increased risk of developing invasive CC (Kessler, 2017). In the United States (US), benefits 
of early detection have not been shared equally by all segments of the population. Racial and 
socioeconomic disparities exist in CC incidence and mortality rates (Garner, 2003). Low income 
and minority women are more likely to be diagnosed at later stages and have higher mortality rates 
(Garner, 2003). Cervical cancer is a preventable disease and any female presenting with invasive 
CC should be viewed as a failure of screening (Garner, 2003). 
Etiology 
 Globally, more than 80% of sexually active individuals acquire genital Human 
Papillomavirus (HPV) infections (Phillip, 2018). In the US, an estimated 6.2 million persons will 
acquire a new HPV infection annually (Phillip, 2018). Infection by high-risk HPV types or strains 
is necessary but not sufficient for the development of CC (Walboomers, 1999). In the US, HPV is 
detected in 99.7% of cervical cancers (McCormack, 2014). The average number of HPV-
attributable cases of CC per year is 11,693 (CDC, 2017). Over 120 types of HPV have been 
identified, and approximately one-third of these infect the squamous epithelia of the genital tract 
(Moody, 2010). Of the genital strains of HPV, which are sexually transmitted, 15 are categorized 
as carcinogenic or high-risk and are considered the causative agents of most cervical cancers 
(Moody, 2010). About 70% of cervical cancers are the result of persistent infection with at least 
one high-risk strain of HPV (Moody, 2010). In cells persistently infected with HPV, cellular 
mutations accumulate over time, and the infection consequently develops into cancer. Prophylactic 
vaccination is the most effective method of prevention against initial infection of high-risk types 
of HPV (Kessler, 2017; Moody, 2010). However effective, the vaccine cannot protect individuals 
against pre-existing infections, nor do they protect against every type of HPV (Kessler, 2017). 
Thus, women vaccinated or not are encouraged to adhere to CC screening guidelines.  
Risk Factors  
 Persistent infection with a high-risk HPV strain is the principal risk factor for the 
development of CC. The major risk factor for HPV infection is sexual behavior, including early 
age at onset of sexual activity, multiple sexual partners, failure to use barrier methods of 
contraception, and co-infection with other sexually transmitted diseases (Moody, 2010).  
Furthermore, studies have suggested an association between tobacco use and the 
development of CC. Women who smoke cigarettes are twice as likely to develop CC compared 
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with non-smokers (American Cancer Society, 2015). Cigarette smoking has also been suggested 
to increase the risk of HPV-associated malignant transformation (Kanetsky, 1998). Having a 
family history of CC can increase risk by two to three times higher than those with no family 
history (American Cancer Society, 2015). Other studies have suggested that micronutrient 
deficiencies, such as low vitamin c and carotenoid status may contribute to the progression of the 
HPV-induced changes in the cervical epithelium (Potischman, 1996; Weinstein, 2001). Lastly, late 
stage at diagnosis has been identified as the major cause of excess morbidity and mortality in low 
socioeconomic status (SES) and medically under or uninsured populations. Late stage at diagnosis 
is the final result of complex interactions between multiple risk factors, including disparities in 
access to screening, diagnosis, and treatment (Garner, 2003).  
Screening 
Reducing the burden of CC is contingent on primary prevention and early detection. Early 
detection via screening allows time for a medical intervention on precancerous or cancerous 
lesions before the malignant cells invade surrounding tissues (Phillip, 2018). Cervical cancer 
screening by way of Papanicolaou cytology testing (Pap test, Pap smear) is well integrated into the 
US health care system and is widely accepted by women (Tiro, 2007). When Pap test results are 
determined to be abnormal, a colposcopy assessment will be completed, followed by biopsies of 
high-grade lesions, and finally, treatment of biopsy-proven high-grade lesions (Phillip, 2018). 
Women with precancerous lesions who are treated have nearly a 100% 5-year survival rate 
(Kessler, 2017; Walboomers, 1999). The process of screening, triage, and treatment is 
cumbersome, and noncompliance at any point renders this process ineffective (Phillip, 2018). In 
the US, screening is opportunistic: generally, women are tested when they present for care, usually 
at annual visits; thus, not all women receive the recommended screening nor receive the screening 
in a timely manner (Kessler, 2017, Phillip, 2018). 
Current Recommendations 
Currently, the United States Preventive Task Force (USPTF) recommends a Pap test once 
every three years for women aged 21 to 65 (USPTF, 2015). As an alternative, women aged 30 to 
65 who wish to be screened less regularly may choose the combination of cytology and HPV 
testing once every five years (USPTF, 2015). These recommendations apply to women, 
irrespective of sexual history, who have a cervix and display no signs or symptoms of CC (USPTF, 
2015). After completing a potential harm to benefit analysis, the USPTF recommends against the 
screening of women who have had a hysterectomy with removal of the cervix, women younger 
than 21, or women older than age 65 who have a history of being adequately screened (USPTF, 
2015). According to a Centers for Disease Control and Prevention Morbidity and Mortality 
Weekly Report published in 2015, the percentage of women in the US receiving the recommended 
screening was only 80%, and the rate was declining (White, 2015). In response, a Healthy People 
2020 cancer-related objective is to increase the proportion of women aged 21 to 65 who receive a 
screening based on the most recent guidelines to 93% (HP2020, 2010). 
Disparities in Burden 
The American Cancer Society projected 12,820 new cases of invasive CC to be diagnosed 
with 4,210 resultant deaths in the US in 2017 (American Cancer Society, 2016). Cervical cancer 
remains 14th in frequency among all cancers, and the southern states have disproportionately high 
CC incidence and mortality rates (Kessler, 2017; NIH, 2013). This suggests that not all sectors of 
the US population have shared the benefits of early CC detection via Pap test screening equally. 
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In 2013, Arkansas (AR) had one of the highest cervical cancer incidences of 9.9 per 
100,000 person-year, while the national average was 8.2 per 100,000 person-year (CDC, 2016). 
The total population in AR includes several subpopulations which are traditionally 
underrepresented in well-established cohorts (Bondurant, 2011). Rural, minority and lower 
socioeconomic communities exist both in combination and separately within the state (Bondurant, 
2011). According to 2017 census population estimates, of the total population, 42% lived in a rural 
community, 15.7% were African American, and 17.2% of Arkansans lived in poverty (US Census, 
2017).  
Disparities in the burden of CC are exposed when comparing incidence and mortality rates 
regarding education, income and occupation, otherwise known as socioeconomic status. 
Congruently, the National Health Interview Survey showed that income and education are better 
predictors of screening compliance than race (Breen & Kessler, 1994). The purpose of this study 
was to assess demographic and behavioral risk factors for CC and to identify potential barriers 
which influence the likelihood of complying with current Pap test recommendations. 
 
METHODS 
Study Design and Population 
The Behavioral Risk Factor Surveillance System (BRFSS) is the nation’s premier system 
of health-related telephone surveys that collect state-level data about residents regarding their 
health-related risk behaviors, chronic health conditions and use of preventative services (BRFSS, 
2014). Our randomized sampling from the most substantial continuously conducted health survey 
is more representative of AR and US populations when compared to previous relevant literature 
(Blackwell et al., 2008, Hiatt et al., 2001, CDC, 2014).  
National data from the 2014 BRFSS was used for both sociodemographic characteristics 
and behavioral risk factors among female participants in AR and the US. BFRSS data included a 
total of 1,587 women in AR and 162,222 in the US who were aged 18 and above and eligible to 
receive Pap tests. Women with a medical history of hysterectomy that included removal of the 
cervix were considered not eligible to receive Pap tests and subsequently excluded from analysis. 
During the survey, participants were asked,  
“Have you not had a Pap test in the past three years?”  
to which they either responded,  
“No, I have had a Pap test in the past three years.”  
or  
“Yes, I have not had a Pap test in the past three years.”  
For this study, “compliant” women reported that they have had a Pap test in the past three 
years while “non-compliant” women reported that they had not. We examined compliance with 
Pap test screening by age group, race (White, Black, Asian and Others), household income, 
education (<=12-year education versus >12-year education), health insurance coverage, marital 
status, body mass index (BMI), smoking status (current, former, or never), heavy drinker (yes 
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versus no), and public health region of residence (Central, Northeast, Southeast, Southwest, or 
Northwest).  
Statistical Analysis 
Weighted frequencies of demographic and behavioral risk factors were used in this 
analysis. Bivariate analysis was conducted to explore the associations between demographic and 
behavioral risk factors and compliant versus non-compliant with Pap testing among women in AR 
and the US. Multivariate logistic regression was performed to identify risk factors for non-
compliance with Pap test recommendations by controlling for potential confounding variables that 
were determined by a priori and causal graphs. All analyses were performed in Stata 14.0 
(StataCorp LP, College Station, Texas, USA). 
 
RESULTS 
Demographics and behavioral characteristics of women in AR and the US 
Of 1,587 women aged 18 and above in AR, the majority were aged 45 years old or older 
(74%), White (78%), had an average household income of less than $50,000 per year (73%), had 
health care insurance (90%), received more than 12 years of education (55%), overweight or obese 
(60%), a current or former smoker (76%), a heavy drinker (95%), and lived in an urban area (58%) 
(Table 1).  
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Table 1 
Demographics and Behavioral Characteristics of Women in 
Arkansas 
 
  Have had Pap test (Compliant) Have not had Pap test (Non-compliant) 
P-value* 
  N=1,126 
Percentage 
(%) 
Weighted 
Percentage 
(%) 
N=461 Percentage (%) 
Weighted 
Percentage 
(%) 
Age group       <0.001 
18-24 40 87.0 84.5 6 13.0 15.3   
25-34 156 91.2 87.1 15 8.8 12.7   
35-44 161 82.6 81.1 34 17.4 18.9   
45-54 212 82.5 79.5 45 17.5 20.5   
55-64 229 72.0 68.6 89 28.0 31.4   
65 or older 328 54.7 56.6 272 45.3 43.4   
Race       0.02 
White 847 68.4 75.0 392 31.6 25.0   
Black 196 82.4 90.4 42 17.6 9.6   
Asian 36 90.0 84.4 4 10.0 15.6   
others 47 67.1 68.1 23 32.9 31.9   
Household income       0.004 
>$50,000 363 83.8 87.2 70 16.2 12.8   
$35,000-$50,000 142 76.8 79.9 43 23.2 20.1   
$25,000-$35,000 116 62.4 73.2 70 37.6 26.8   
$15,000-$25,000 197 65.9 75.1 102 34.1 24.9   
<$15,000 137 60.9 69.3 88 39.1 30.7   
Education       <0.001 
<= 12-year education 453 63.5 70.3 260 36.5 29.7   
>12-year education 669 77.0 84.2 200 23.0 15.8   
Health care insurance       0.001 
Yes 1025 71.4 79.4 410 28.6 20.6   
No 95 66.4 66.9 48 33.6 33.1   
Marital status       0.08 
Married 589 76.8 79.7 178 23.2 20.3   
Divorced/widowed/separated 383 61.6 69.1 239 38.4 30.9   
Never Married 125 79.1 83.1 33 20.9 16.9   
Unmarried couple 22 73.3 76.7 8 26.7 23.3   
BMI       0.98 
Underweight (BMI<18.5) 20 58.8 75.9 14 41.2 24.1   
Normal (18.5-25) 344 67.7 76.6 164 32.3 23.4   
Overweight (25-30) 325 72.4 78.2 124 27.6 21.8   
Obese (>30) 367 73.3 77.6 134 26.7 22.4   
Smoking status       <0.001 
Current smoker 681 75.0 84.0 227 25.0 16.0   
Former smoker 192 64.6 64.5 105 35.4 35.5   
Never smoked 248 66.7 75.4 124 33.3 24.6   
Heavy drinker       <0.001 
Yes 1,064 70.5 77.1 445 29.5 22.9   
No 50 78.1 80.3 14 21.9 19.7   
Public health regions       0.01 
Central 310 78.9 83.5 83 21.1 16.5   
Northeast 166 64.8 73.6 90 35.2 26.4   
Southeast 136 70.1 77.0 58 29.9 23.0   
Southwest 100 58.1 81.3 72 41.9 18.7   
Northwest 362 71.3 64.8 146 28.7 35.2   
*P-values were corrected for weights.         
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Table 2 
Risk Factors for non-compliance among women  
in Arkansas 
 Odds ratios (95% confidence interval [CI])* in Arkansas 
  Point estimate Lower Band of 95% CI Upper Band of 95% CI 
Age group     
18-24 Ref Ref Ref 
25-34 0.68 0.17 2.79 
35-44 2.07 0.48 8.81 
45-54 2.22 0.54 9.10 
55-64 5.10 1.28 20.28 
65 or older 11.06 2.93 41.84 
Race     
White Ref Ref Ref 
Black 0.12 0.04 0.32 
Asian 0.26 0.04 1.76 
others 2.15 0.84 5.50 
Household income     
>$50,000 Ref Ref Ref 
$35,000-$50,000 0.85 0.39 1.88 
$25,000-$35,000 1.59 0.83 3.05 
$15,000-$25,000 1.21 0.56 2.63 
<$15,000 1.89 0.84 4.24 
Education     
<= 12-year education Ref Ref Ref 
>12-year education 0.59 0.36 0.96 
Health care insurance     
Yes Ref Ref Ref 
No 3.56 1.66 7.66 
Marital status     
Married Ref Ref Ref 
Divorced/widowed/separated 0.92 0.54 1.57 
Never Married 1.67 0.57 4.87 
Unmarried couple 0.77 0.12 5.20 
BMI     
Normal (18.5-25) Ref Ref Ref 
Underweight (BMI<18.5) 1.10 0.37 3.26 
Overweight (25-30) 0.90 0.51 1.57 
Obese (>30) 1.09 0.63 1.88 
Smoking status     
Never smoked Ref Ref Ref 
Current smoker 3.96 2.25 6.94 
Former smoker 1.06 0.67 1.68 
Heavy drinker     
Yes Ref Ref Ref 
No 0.72 0.25 2.13 
Public health regions     
Central Ref Ref Ref 
Northeast 1.03 0.47 2.25 
Southeast 1.23 0.47 3.24 
Southwest 1.86 0.93 3.72 
Northwest 0.99 0.53 1.86 
*Odds ratios were corrected for weights.       
 
Women who were non-compliant with Pap testing were more likely to be older, White, less 
educated, uninsured, and a current or former smoker, a heavy drinker, have a lower household 
income and live in rural area. The demographic characteristics in the national survey were similar 
to those in AR (Table 3). 
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Risk factors for non-compliance among women in AR and the US 
Tables 2 and 4 present results from multivariable logistic regression. The odds of non-
compliance with Pap testing increased along with age in the national survey (Table 4). Among 
women in AR, women aged 65 and older were most likely to be non-compliant with Pap testing 
(adjusted Odds Ratio (aOR) 11.06, 95% confidence interval (CI) 2.93-41.84). Black women were 
Table 3 
Demographics and Behavioral Characteristics of Women in 
United States 
 
  Have had Pap test (Compliant) Have not had Pap test (Non-compliant) 
P-value* 
  N=127,327 
Percentage 
(%) 
Weighted 
Percentage 
(%) 
N=34,895 
Percentage 
(%) 
Weighted 
Percentage 
(%) 
Age group       <0.001 
18-24 5483 95.1 95.3 282 4.9 4.7   
25-34 17358 91.8 92.3 1548 8.2 7.7   
35-44 21848 88.6 88.8 2821 11.4 11.2   
45-54 26113 85.4 86.6 4457 14.6 13.4   
55-64 30173 81.1 81.3 7052 18.9 18.7   
65 or older 26352 58.4 61.1 18735 41.6 38.9   
Race       <0.001 
White 97,647 76.7 81.9 29649 23.3 18.1   
Black 10849 87.2 90.3 1588 12.8 9.7   
Asian 11192 85.4 88.6 1919 14.6 11.4   
others 7639 81.5 86.3 1739 18.5 13.7   
Household income       0.001 
>$50,000 57017 87.2 89.7 8360 12.8 10.3   
$35,000-$50,000 15718 78.0 83.7 4424 22.0 16.3   
$25,000-$35,000 11,018 72.2 79.7 4238 27.8 20.3   
$15,000-$25,000 16229 69.1 79.8 7258 30.9 20.2   
<$15,000 11124 70.0 79.0 4775 30.0 21.0   
Education       <0.001 
<= 12-year education 36,554 71.5 79.5 14,551 28.5 20.5   
>12-year education 90,505 81.7 87.0 20,245 18.3 13.0   
Health care insurance       0.001 
Yes 118164 79.3 85.3 30919 20.7 14.7   
No 8912 69.6 77.3 3885 30.4 22.7   
Marital status       0.08 
Married 71823 83.5 86.3 14167 16.5 13.7   
Divorced/widowed/separated 32572 66.7 73.3 16238 33.3 26.7   
Never Married 18204 83.5 89.5 3601 16.5 10.5   
Unmarried couple 4065 85.5 89.3 692 14.5 10.7   
BMI       <0.001 
Underweight (BMI<18.5) 2,235 69.4 80.7 987 30.6 19.3   
Normal (18.5-25) 47604 79.7 85.6 12154 20.3 14.4   
Overweight (25-30) 36503 78.5 84.4 9993 21.5 15.6   
Obese (>30) 32981 77.4 82.5 9609 22.6 17.5   
Smoking status       <0.001 
Current smoker 79792 81.3 87.1 18305 18.7 12.9   
Former smoker 17144 73.3 78.3 6257 26.7 21.7   
Never smoked 29833 74.6 80.1 10134 25.4 19.9   
Heavy drinker       <0.001 
Yes 118,055 78.4 84.2 32589 21.6 15.8   
No 7425 80.7 84.5 1778 19.3 15.5   
Public health regions       <0.001 
Northeast 25923 81.1 85.7 6,060 18.9 14.3   
Midwest 33947 76.9 82.8 10197 23.1 17.2   
South 36893 79.8 84.3 9336 20.2 15.7   
West 27817 76.1 84.3 8,734 23.9 15.7   
*P-values were corrected for weights.             
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88% (aOR 0.12, 95% CI 0.04-0.32) and 56% (aOR 0.44, 95% CI 0.39-0.51) more likely to have 
had a Pap test in the past three years compared to their White counterparts in AR and the US, 
respectively. A similar finding was also observed among Asians.  
 
An inverse trend in the odds of non-compliance with Pap testing was observed along with 
decreased household income in the national survey. Women with a household income of less than 
$15,000 were most likely not to have had a Pap test in the past three years (aOR 1.99, 95% CI 
Table 4 
Risk factors for non-compliance among women in  
United States 
 Odds ratios (95% confidence interval [CI])* in the US 
  
Point 
estimate Lower Band of 95% CI Upper Band of 95% CI 
Age group     
18-24 Ref Ref Ref 
25-34 1.84 1.44 2.35 
35-44 3.57 2.80 4.56 
45-54 4.33 3.40 5.51 
55-64 6.68 5.25 8.50 
65 or older 19.31 15.16 24.58 
Race     
White Ref Ref Ref 
Black 0.44 0.39 0.51 
Asian 0.47 0.41 0.54 
others 0.84 0.69 1.03 
Household income     
>$50,000 Ref Ref Ref 
$35,000-$50,000 1.38 1.25 1.52 
$25,000-$35,000 1.76 1.57 1.96 
$15,000-$25,000 1.75 1.57 1.95 
<$15,000 1.99 1.76 2.25 
Education     
<= 12-year education Ref Ref Ref 
>12-year education 0.87 0.80 0.93 
Health care insurance     
Yes Ref Ref Ref 
No 2.78 2.51 3.08 
Marital status     
Married Ref Ref Ref 
Divorced/widowed/separated 1.18 1.09 1.27 
Never Married 1.18 1.06 1.32 
Unmarried couple 1.00 0.83 1.21 
BMI     
Normal (18.5-25) Ref Ref Ref 
Underweight (BMI<18.5) 1.23 1.02 1.49 
Overweight (25-30) 0.97 0.90 1.05 
Obese (>30) 1.20 1.11 1.30 
Smoking status     
Never smoked Ref Ref Ref 
Current smoker 1.77 1.63 1.92 
Former smoker 1.13 1.05 1.22 
Heavy drinker     
Yes Ref Ref Ref 
No 1.09 0.97 1.23 
Public health regions     
Northeast Ref Ref Ref 
Midwest 1.29 1.18 1.41 
South 1.25 1.15 1.36 
West 1.31 1.17 1.45 
*Odds ratios were corrected for weights.       
158 Comparison of Compliance with Cervical Cancer Screening among Women aged 18 and 
above in Arkansas and the United States--O’Connor, Tao, and Su 
Journal of Health Disparities Research and Practice Volume 11, Issue 4, Winter 2018 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
1.76-2.25). In AR, a similar pattern was found with an exception that women with a household 
income of $35,000-$50,000. Women with more than 12 years of education were 41% (aOR 0.59, 
95% CI 0.36-0.96) and 13% (aOR 0.87, 95% CI 0.80-0.93) more likely to have a Pap test in the 
past three years in AR and the US, respectively.  
Uninsured women were approximately two times more likely to not comply with Pap 
testing in AR (aOR 3.56, 95% CI 1.66-7.66) and the US (aOR 2.78, 95% CI 2.51-3.08) than women 
with insurance. The association of current tobacco smokers and non-compliance with Pap testing 
in AR (aOR 3.96, 95% CI 2.25-6.94) was stronger than that in the US (aOR 1.77, 95% CI 1.63-
1.92).  
 
DISCUSSION 
Numerous studies have shown that most women who develop CC in developed countries, 
especially those presenting at advanced stages, are inadequately screened (Phillip, 2018). 
Researchers have suggested SES, age, race, and access to medical insurance facilitate or contrarily, 
limit compliance with recommended screening for CC. Both Krieger et al. (1999) and Liu et al. 
(1998) reported SES as inversely associated with cervical cancer incidence. Krieger et al. (1999) 
reported CC incidence rates varied as much by SES than by race and ethnicity. Our results were 
in agreement with these studies as our results included household income and education, both 
components of SES, exhibited strong associations with likeliness to comply with Pap testing. 
Women who lived in households with an average income of less than $15,000 were the least likely 
to receive regular Pap tests. It is likely that these women do not qualify for and cannot afford 
quality health insurance which would cover the cost of screening.  
Similar to our study design, D.L. Blackwell et al. (2008) examined compliance with current 
national Pap test guidelines among US and Canadian women. Investigators found that younger age 
was strongly associated with the odds of having a Pap test. The odds of having a Pap test were 
lower among older women relative to women aged 18 to 29. Our results among women in AR 
suggest a similar pattern of compliance being inversely associated with age. Although the current 
guidelines recommend against screening past the age of 65 (USPTF, 2015), this recommendation 
is contingent on having a personal history of adequate screening or having had a hysterectomy. 
Additionally, Blackwell et al. (2008) reported non-Hispanic black women in the US were 
more likely to be compliant with Pap testing guidelines than non-Hispanic white women. Our 
results were in agreement. Surprisingly, though, Black women in some areas of the US have higher 
screening Pap test rates (Makuc, 1989), but are still diagnosed in later stages and have higher 
mortality than their white counterparts. This is possibly due to inadequate follow-up systems for 
women who have received abnormal Pap test results. Furthermore, system-level barriers exist 
beyond inadequate follow-up recommendations. The quality of health care being received, 
perceived racism and discrimination, medical mistrust, and a lack of culturally sensitive, 
linguistically appropriate educational interventions create barriers throughout the process of 
screening, follow-up, and treatment. 
Lastly, our results presented medical insurance as a significant barrier to compliance with 
Pap testing. Several studies have reported that medically under or uninsured women have lower 
cancer screening rates and often present at later stages of the disease (Garner, 2003). Hiatt et al. 
(2001) found that the strongest predictors of cancer screening were having private health insurance 
and frequent use of medical services. 
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Arkansas has the second highest cervical cancer incidence and mortality rate among all 
states in the US (CDC, 2016). It is not surprising to see that there is a significant disparity in Pap 
test compliance among women in AR in every sociodemographic sector when compared to the US 
average. Income and education are significant barriers for Pap test compliance in AR, which is 
consistent with the finding in the US. 
 
CONCLUSION 
 Future cervical cancer screening interventions in AR should target the promotion of Pap 
test compliance among women of color, with low SES, and the medically under or uninsured. 
Linguistically-appropriate educational interventions should be employed inside high-risk 
communities and should inform about what CC is, associated risk factors, current screening 
guidelines, and what a Pap test is and involves. Reduced or no-cost Pap testing clinics in such 
communities would provide medical professionals with a platform for educating patients. 
Furthermore, taking the reduced or no-cost Pap testing opportunity to women who live in rural 
areas by way of a mobile unit would decrease barriers to compliance often posed by geographical 
distance and transportation. The prospective benefits of culturally-competent educational 
interventions include decreasing the stigma associated with HPV infection and increasing 
knowledge of the potentially lifesaving importance of receiving a Pap test once every three years. 
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